Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Disease Severity and Healthcare Costs Associated With Chronic Kidney Disease in Patients With Systemic Lupus Erythematosus.
Journal: Clinical therapeutics
Published: July 11, 2025
Criteria and Protocol: Assessing Generative AI Efficacy in Perceiving EULAR 2019 Lupus Classification.
Journal: Diagnostics (Basel, Switzerland)
Published: July 01, 2025
Clinical Outcomes of Patients with SLE Treated with Belimumab, Without Versus With Prior Immunosuppressant Use: a US Claims Database Study.
Journal: Rheumatology and therapy
Published: March 04, 2025
Prediction of Lupus Classification Criteria via Generative AI Medical Record Profiling.
Journal: Biotech (Basel (Switzerland))
Published: January 16, 2025
Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents.
Journal: Rheumatology and therapy
Published: November 11, 2024
Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point-of-Care Feasibility Study.
Journal: Arthritis care & research
Published: October 10, 2024
Impact of a digital platform and flare risk blood biomarker index on lupus: A study protocol design for evaluating self efficacy and disease management.
Journal: Contemporary clinical trials communications
Published: August 02, 2024
Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period.
Journal: BMC health services research
Published: March 12, 2024
Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study.
Journal: Rheumatology and therapy
Published: February 21, 2024
Correction: Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study.
Journal: Rheumatology and therapy
Published: November 23, 2023
Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count.
Journal: Lupus science & medicine
Published: November 22, 2023
Last Updated: 09/26/2026